Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study to Compare Cognitive Outcome After Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Patients With 11-20 Brain Metastases

NCT02953717 is registered in ClinicalTrials.gov with Elisabeth-TweeSteden Ziekenhuis as lead sponsor.

NCT NCT02953717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02953717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study to Compare Cognitive Outcome After Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Patients With 11-20 Brain Metastases
Lead sponsor
Elisabeth-TweeSteden Ziekenhuis
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
January 11, 2023
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm metastasis